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Abstract
Introduction: Not sedating critically ill patients reduces the time patients receive mechanical ventilation, decreases
the time in the intensive care department and reduces the total hospital length of stay. We hypothesized that no
sedation improves hemodynamic stability, decreases the need for vasoactive drugs, diminishes the need for extra
fluids and lowers the risk of acute kidney injury.
Methods: We performed an evaluation on the database from our previous trial of 140 patients randomized to
either no sedation vs. sedation with a daily interruption of sedatives. A total of 113 patients were included in the
previous statistical analysis. Ten patients had pre-existing renal impairments and were excluded. Data were
collected from observational cards and blood samples.
Results: A total of 103 patients were included in this retrospective review. We registered an increased urine output
in the group receiving no sedation compared to the sedated control group (1.15 ml/kg/hour (0.59 to 1.53) vs. 0.88
ml/kg/hour (0.052 to 1.26), P = 0.03). In addition we saw a decrease in the number of patients with renal
impairment according to the RIFLE classification (indicating Risk of renal dysfunction; Injury to the kidney; Failure of
kidney function, Loss of kidney function and End-stage kidney disease) in the group receiving no sedation
compared to the sedated control group (25 (51%) vs. 41 (76%), P = 0.012). The difference in the two groups with
respect to mean arterial blood pressure, fluid balance and use of vasoactive drugs was not significant.
Conclusions: A no sedation strategy to patients undergoing mechanical ventilation increases the urine output and
decreases the number of patients with renal impairments.
Trial registration: ClinicalTrials.gov registration number NCT00466492.
Introduction
Sedation is used in critically ill patients receiving
mechanical ventilation to bring the patients comfort and
facilitate mechanical ventilation during intensive care
stay [1]. The intention is to sedate and thereby depress
the central nervous system (CNS). But sedation not only
affects the brain, it also has an effect on many other
organs. A common complication to bolus doses of seda-
tive drugs is a decrease in blood pressure. Counter mea-
sures are often applied such as infusion of intravenous
fluid and initiation of vasopressor drugs to keep the
blood pressure within normal range. The effect of contin-
uous use of sedation, compared to a no sedation strategy,
on organ function has not yet been described.
Kress and colleagues showed that a daily interruption
of sedatives reduced the time patients receive mechanical
ventilation and reduced the intensive care length of stay
[2]. However, no difference was found with respect to
total hospital length of stay. The same group also made a
retrospective evaluation of the number of complications
between the two study groups: sedation with daily inter-
ruption of sedatives or continuous sedation without daily
interruption of sedatives [3]. They were able to report a
higher number of complications in the continuously
sedated control group. Girard and colleagues have shown
that combining both a daily interruption of sedatives and
a spontaneous breathing trial, compared to only sponta-
neous breathing, not only reduced time in mechanical
ventilation but also decreased total hospital length of stay
and 365 days mortality [4].
We have recently published a trial showing that the
use of a no sedation strategy to critically ill patients
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of ventilator free days and decreased both intensive care
unit and total hospital length of stay [5]. Especially the
observation that a reduction in sedation in the intensive
care unit also reduced total hospital length of stay made
us perform this not ap r i o r idefined post hoc analysis of
data from the original study. We observed that patients
from the sedated control group more often developed a
degree of renal impairment compared to patients from
the awake intervention group. To further elucidate the
effect of sedation is vital for our understanding of the
consequences with routine use of sedation. Our main
hypothesis in this subgroup analysis was that a strategy
with no sedation would improve hemodynamic stability
(mean arterial pressure); decrease the need for vasoac-
tive drugs; diminish the need for extra fluid; and
improve renal function.
Materials and methods
Patients and study intervention
In the original study we included patients who were
expected to receive mechanical ventilation for more
than 24 hours. The inclusion criteria were: age above 17
years, not pregnant, and not in need of sedation because
of increased intracranial pressure or undergoing thera-
peutic hypothermia. We excluded patients who were not
expected to wake up with or without sedation (coma
hepaticum or neurological coma). A total of 140 patients
were randomized in two groups: 70 patients in the
awake intervention group and 70 patients in the sedated
control group. The intervention group received no seda-
tion except for bolus doses of morphine. The sedated
control group also received bolus doses of morphine
and infusion of propofol titrated to reach a RAMSAY
score of 3 to 4 [6]. After 48 hours propofol was changed
to midazolam. In the sedated control group, we per-
formed a daily interruption of sedatives as described by
Kress et al. [2]. Patients who either had their endotra-
cheal tube successfully removed or died within 48 hours
were excluded from the statistical analysis. In this sub-
group analysis, patients with a prior history of renal
insufficiency (glomerular filtration rate (GFR) below 60
ml/minutes for more than three months [7]) or prior
dependency on intermittent dialysis were excluded. This
database was provided to investigators (RRJ and JOP)
not involved in the original study. They then reviewed
all patients’ original observation charts. They had no
direct knowledge of the randomized treatment but they
were not completely blinded because all infusions
(including sedatives) could be seen on the observational
charts.
The original study was approved by the local ethics
committee and informed consent was obtained from
each patient or representatives.
Data collection
Baseline data (age, gender, weight, Acute Physiology and
Chronic Health Evaluation (APACHE II) and Sequential
Organ Failure Assessment (SOFA) at Day 1) were
recorded. The time each patient was dependent on con-
trolled ventilation was also recorded as a baseline value.
Once intubated, patients were shifted, as quickly as pos-
sible, from pressure control ventilation to pressure sup-
port ventilation. This modus is the standard ventilation
modus in our department. Mean arterial blood pressure
(four times a day at 6 o clock in the morning, noon, 6 o
clock in the evening and midnight), use of vasopressor
or inotropic drugs, urine output, total amount of fluids
was recorded. Results of serum levels of creatinine were
also recorded. The RIFLE criteria were adopted from
the Acute Kidney Injury Network (AKIN) [8]. The
RIFLE classification was defined as follows: RIFLE cri-
teria Risk is defined as: increase in serum creatinine of
≥26.4 μmol/l (150 to 200% of baseline) or urine output
of <0.5 ml/kg/h for >6 h. RIFLE criteria Injury is defined
as: increase in serum creatinine to >200 to 300% of
baseline or urine output <0.5 ml/kg/h for >12 h. RIFLE
criteria Failure is defined as: increase in serum creati-
nine to >300% of baseline (serum creatinine ≥354 μmol/
l with an acute rise of at least 44 μmol/l) or urine out-
put <0.3 ml/kg/h for 24 h or anuria for 12 h. Patients
who received renal replacement therapy was considered
to have met the criteria for failure, irrespective of the
stage that they were in at the time of commencement of
renal replacement therapy [8].
The highest value according to the RIFLE classifica-
tion (with respect to urine output and creatinine clear-
ance) was calculated for each patient.
The study objectives
The primary objective of this study was to test whether
a strategy with no sedation would improve hemody-
namic stability (mean arterial pressure); decrease the
need for vasoactive drugs; diminish the need for extra
fluid and lower the risk of acute kidney injury (AKI).
Statistics
The total number of patients not discharged from the ICU
was 44 patients (43%) after a 14-day period. We, therefore,
choose to report data from the first 14 days only. The vari-
ables: mean arterial blood pressure, fluid balance and urine
output are presented in separate figures as mean values
calculated for each day in a 14-day period and drawn sepa-
rately for each group (intervention group with no sedation
and control group with sedation). A mean value for each
patient up to a period of 14 days was calculated and pre-
sented for each variable. Variables for each patient were
used for statistical analysis. For each patient a highest
RIFLE score was calculated for a 14-day period. The data
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patients were divided into two groups: with or without
renal impairment.
Data were compared using Wilcoxon Rank-sum test
and Chi
2 test as appropriate. All tests were performed
using: StataCorp. 2007. Stata Statistical Software: Release
10.1. College Station, TX, USA: StataCorp LP.
Results
We randomized 140 patients from April 2007 to
December 2008. Twenty-seven patients were discontin-
ued from mechanical ventilation within 48 hours either
because of death or successful extubation. Ten patients
had an existing renal insufficiency and were excluded
from this subgroup analysis. A total of 103 patients
were included in the analysis (Figure 1). Baseline data
a r es h o w ni nT a b l e1 .P a t i e nts are comparable with
respect to age, weight, APACHE II, SOFA score, S-crea-
tinine and urine output at Day 1. We found no differ-
ence in the cumulated time patients were dependent on
controlled ventilation modus compared to support
modus. “Patients at risk” and still admitted in the inten-
sive care unit are shown in Table 2. In a 14-day period
we found no statistically significant difference in the
mean arterial blood pressure between the two groups
(Table 3).
The use of vasopressor is shown in Table 3. Noradre-
naline was the most used vasoactive drug in these
patients. The use of dopamine, dobutamine and adrena-
line was very low in both groups (data not shown). No
difference was found in the use of vasopressors. No
difference between the groups was found in the use of
morphine or diuretics (Table 3).
Both groups of patients were in a positive fluid balance
the first five days (Figure 2). After Day 5, both groups
were in zero to slight negative fluid balance. Although it
did not reach statistical significance, a median value of
9.70 ml/kg/day was found in the sedated control group
compared to 4.58 ml/kg/day in the awake intervention
group (P = 0.13). In addition, the cumulative fluid balance
was higher in the sedated group 61.38 (0 to 105.75) ml/kg)
compared to 24.46 (0 to 50.42) ml/kg in the awake inter-
vention group. This difference, however, did not reach
statistical significance.
We found a significantly higher urine output in the
awake group during the first 14 days compared to the
sedated control group (P = 0.03) (Figure 3 and Table 3).
T h i sw a ss e e ne v e nt h o u g hw ef o u n dn od i f f e r e n c ei n
the use of colloids (data not shown) or diuretics
between the two groups.
The renal function expressed according to the RIFLE
classification is shown in Figure 4. The highest value for
each patient in a 14-day period is shown in the histo-
gram. In the first group of patients with normal renal
function there are a higher number of patients from the
non-sedated intervention group. In the other three
groups with different degrees of acute kidney injury
(Risk, Injury or Failure) there is a higher number of
patients from the sedated group. This difference is sta-
tistically significant (P = 0.012). The part of the RIFLE
classification with the highest impact was the low urine
output. Only one patient reached a higher RIFLE class
solely because of a rise in serum creatinine.
There was no difference observed in the number of
patients treated with continuous renal replacement ther-
apy. Eighteen patients from the awake intervention
group started continuous renal replacement therapy and
21 in the sedated control group (P = 0.32) (Table 3).
Discussion
We found that the use of sedation decreased the urine
output and increased the frequency of acute kidney inju-
ries expressed according to the RIFLE classification. This
finding is interesting because Bagshaw and colleagues
observed an association between increase in hospital
mortality and successive increase in severity of RIFLE
category [9]. The increase in acute kidney injuries in the
sedated control group is, therefore, suggestive of a
poorer outcome and might explain a part of the pro-
longed hospital length of stay in this group. A significant
increase in the number of the more severe cases of
patients with acute kidney injuries who needed continu-
ous renal replacement therapy was not demonstrated.
However, the RIFLE classification is a very sensitive
parameter and not all patients classified as having AKI
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140patientsrandomized
27patientsexcluded
becauseoflessthan48
hoursreceivingmechanical
ventilation
10patientsexcluded
becauseofpreexistingrenal
impairment(seeonline
supplement).
103patientsincludedinthe
statisticalanalysis
Figure 1 Consort diagram.
Strøm et al. Critical Care 2011, 15:R119
http://ccforum.com/content/15/3/R119
Page 3 of 6according to the RIFLE classification receives renal
replacement therapy during their ICU stay.
No difference was found in blood pressure between
the two groups. One might ap r i o r isuspect that this
lack of difference in blood pressure (data not shown)
could be explained by an increased use of vasoactive
drugs and fluids in the sedated control group. Surpris-
ingly we found no statistical difference in the use of
vasoactive drugs, fluid balance, and the use of colloids
or diuretics during the first 14 days.
The mechanism behind the renal impairment
observed in our study is not known. A decrease in the
microcirculation within the kidneys following sedation
might be part of the explanation. Sedation probably has
an impact on other organs such as the gastrointestinal
tract, kidneys and lungs. It is difficult to monitor the
end organ perfusion and a clear explanation cannot be
concluded with our present data. It is, however, likely
that our present findings with decreased urine output
and increased risk of AKI evaluated in with the RIFLE
classification in the sedated group have a multifactorial
origin from the use of sedation. Koch and colleagues
found that the use of propofol in patients undergoing
elective surgery reduced the microcirculation [10].
Although we only used propofol for a maximum of 48
hours and then switched to midazolom, a reduction in
microcirculation could explain some of our findings.
The observed renal impairm e n ti n d u c e db yt h eu s eo f
sedative drugs in the present study might explain part of
the prolonged hospital length of stay.
The use of sedation has several other disadvantages.
Sedation eliminates the possibility to clinically observe
the cerebral function of patients and complicates the
ability to detect delirium since Richmond Agitation-
Sedation Scale (RASS) needs to be at least -3 or above
to use the CAM-ICU score to detect delirium [11-13].
CNS function is a very important parameter in the con-
tinuous observation of the critically ill patient. The
drugs used to induce sedation are not organ specific.
The use of sedation could cause a need for vasopressors
or fluids to counteract the vasodilatation introduced by
the use of sedation in the critically ill patient. The use
of vasopressor agents to counteract a reduction in blood
pressure does not increase the microcirculation in criti-
cally ill patients. This was demonstrated by Dubin and
colleagues who increased the mean arterial pressure
above 65 mmHg in patients with septic shock [14]. This
elevation of blood pressure did not increase the
microcirculation.
The use of pressure support ventilation as the preferred
ventilator strategy differs from the generally used ventila-
tion modus for critically ill patients, which is controlled
ventilation [15]. It is our policy to shift the ventilator
modus to pressure support as soon as the patients are able
to trigger the ventilator. Ap r i o r ione would expect the use
of sedation to decrease the patient’s ability to interact with
the ventilator, thereby prolonging the need for mechanical
ventilation for the sedated patients. This would also be an
obvious factor in explaining the observed renal effects of
sedation. Surprisingly, we found no difference between the
two groups in the time patients needed controlled ventila-
tion. As earlier reported, the total amount of sedatives
used in the sedated group was low which could explain
the ability to trigger the ventilator [5]. However, as earlier
demonstrated, the total time receiving mechanical ventila-
tion (controlled ventilation and pressure support) was
increased by the use of sedation.
This study holds several limitations. It was not an a
priori planned study and only included a single center
with relatively few patients. It was, therefore, not powered
to detect a difference in renal function or fluid balance.
The observed difference in urine output could be because
of a type I error and simply an observation done by
chance. Also, the fact that no differences were found in
Table 1 Baseline characteristics on admission to intensive care unit
Intervention group
(n = 49)
Control group
(n = 54)
P-value
Age (years) 67 (55 to 73) 64.5 (56 to 74) 0.88
Gender (female) 13 (26.5%) 23 (42.6%) 0.08
Weight (kg) 80 (70 to 92) 76 (69 to 91) 0.40
APACHE II score 24 (19 to 30) 26 (22 to 29) 0.30
SOFA score (Day 1) 7 (5 to 11) 9 (6 to 12) 0.34
Urine output ml/kg/hour Day 1 0.35 (0.13 to 0.82) 0.25 (0.11 to 0.85) 0.53
Serum creatinine mikromol/l (Day 1) 122 (93 to 181) 157 (99 to 219.5) 0.26
Data are in median (IQR) or number (%). APACHE II: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment.
Table 2 Number of patients at risk (admitted to ICU) in a
14-day period
D a y 1234567891 0 1 1 1 2 1 3 1 4
Not
sedated
49 49 46 43 37 32 29 26 25 24 22 21 20 18
Sedated 54 54 49 46 45 44 42 40 38 36 33 31 27 26
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use of vasopressors is challenging. However, the study was
conducted in an institution with no sedation as standard
care. The sedated control group was less sedated than cen-
ters with routine use of sedation. Still we found a differ-
ence in urine output which is an important message with
the widespread routine use sedatives [16,17].
We choose only to report data from up to a 14-day
period because of the very different number of days
patients were admitted to the intensive care department
(see Table 2). Reporting and analysing a longer time
interval would hold a risk that data from only a few
patients would be amplified and perhaps give a mislead-
ing result. The SAFE (Saline versus Albumin Fluid Eva-
luation) Study Investigators recently published a
subgroup analysis only reporting data from the first
seven days [18]. In our opinion, the 14 days represents a
good compromise between an acceptable time frame
and a representative number of patients (Table 2).
Prospective randomized studies are difficult and time
consuming to conduct but they are still the gold stan-
dard for proving or rejecting new knowledge. A not a
priori defined finding from a prospective single center
study always holds a risk of being a random finding
(type 1 error). However, subgroup analysis data from
prospective randomized trials are important in designing
new studies aimed at proving or rejecting a hypothesis.
A prospective randomized multicenter study, powered
to detect difference in fluid balance, renal function and
mortality is now warranted.
Conclusions
I nt h ep r e s e n ts t u d yw es h o w e dt h a tas t r a t e g yw i t hn o
sedation resulted in less renal impairment evaluated by
urine output and RIFLE classification compared to the
use of sedation. No difference in blood pressure or the
need for vasopressor agents was observed. A large pro-
spective multicenter study with renal impairment as one
Table 3 Results table
Intervention group
(n = 49)
Control group
(n = 54)
P value
Arterial blood pressure mmHg 81 (75 to 88) 77 (75 to 85) 0.24
Noradrenaline ml/hour/day* 0.11 (0 to 0.68) 0.07 (0 to 0.74) 0.64
Morphine mikrog/kg/hour $ 5.16 (1.25 to 11.07) 4.51 (2.02 to 6.40) 0.40
Diuretics (furosemide) mg/kg/day 0.23 (0.09 to 0.38) 0.19 (0.05 to 0.38) 0.38
Fluid balance ml/kg/day 4.58 ((-0.13) to 9.88) 9.70 ((-2.03) to 22.79) 0.13
Total cumulative fluid balance ml/kg 24.46 (0 to 50.42) 61.38 (0 to 105.75) 0.38
Urine output ml/kg/hour 1.15 (0.59 to 1.53) 0.88 (0.052 to 1.26) 0.03
Number of patients starting CRRT 18 (33%) 21 (43%) 0.32
Number of patients with renal impairment** 25 (51%) 41 (76%) 0.012
Cumulated time dependent on controlled ventilation Days # 0.46 (0.13 to 1.79) 0.46 (0.21 to 2.25) 0.56
All values in median (IQR) or number (%). Each value is calculated from a mean for each patient in the first 14 days of their intensive care stay. *One milliliter
corresponds to 0.01 μg/kg/minute. CRRT: continuous renal replacement therapy. $, Morphine median value for entire period of mechanical ventilation. ** Renal
impairment according to RIFLE class Risk, Injury or Failure. #, Time before patients was shifted to support ventilation.
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sedation causes renal impairment is now warranted.
Key messages
￿ Routine use of sedatives prolonged the time patients
received mechanical ventilation and length of stay
￿ This post hoc analysis suggests an increase in acute
kidney injury with the use of sedation compared to a
strategy with no sedation
￿ No significant difference was found with respect to
the use of vasopressors or fluid balance
￿ A larger multicenter study is needed to verify the
thesis that sedation increase the risk of acute kidney
injury
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